Laura Carter - 04 May 2022 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Scientific Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
04 May 2022
Net transactions value
-$9,086
Form type
4
Filing time
05 May 2022, 18:14:56 UTC
Previous filing
17 Mar 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Sale $9,086 -1,262 -1.4% $7.20* 89,042 04 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.